Amgen sues Roche over new anaemia treatment
November 22, 2005Sales and Marketing
Roche has released new phase II data for a highly promising new anaemia treatment – but Amgen are determined to …
New antibody could be COPD breakthrough, say companies
November 21, 2005Research and Development Argenta, COPD, Domantis
Two UK biotech companies say their innovative antibody drug could be a breakthrough in treating the chronic respiratory disease COPD.Chronic …
Asthma drug warning hits GlaxoSmithKline
November 21, 2005Sales and Marketing
Sales of GlaxoSmithKline's number one product asthma drug Advair could be hit by new safety warnings imposed by the US …
Oxford and GSK to collaborate on cancer research in India
November 18, 2005Research and Development
The University of Oxford and GlaxoSmithKline are to work together with researchers in India to set up the country's first …
Which company is pharma’s rising star?
November 17, 2005Sales and Marketing
Pharmaceutical executives are voting in their hundreds every week in a unique survey to find out which companies are the …
Patient demand brings Sativex to UK ahead of approval
November 17, 2005Sales and Marketing GW Pharmaceuticals, Sativex
The unlicensed cannabis-based medicine Sativex will be available in the UK to treat neuropathic pain on a named patient basis …
Haringey spawns new NHS collaboration for Pfizer
November 17, 2005Pfizer's high profile disease management project with Haringey Teaching PCT looks set to be declared a success – and has …
De Facto expands into med ed
November 17, 2005Medical Communications
PR firm De Facto has launched a medical education arm and signed up its first two clients for the new …
Stricter new UK industry code of practice launched
November 16, 2005Medical Communications, Sales and Marketing
The UK pharmaceutical industry is to adopt a new stricter code of conduct to help distance itself from allegations of …
Study results not IDEAL for Lipitor
November 16, 2005Research and Development, Sales and Marketing
A new study of Lipitor failed to show it was better than Merck's Zocor at preventing major coronary events.Results showing …
Complete prescribing power proposed for nurses and pharmacists
November 15, 2005Some nurses and pharmacists could soon be able to prescribe almost any drug available on the NHS under sweeping changes …
Government should stay out of NHS medicines decisions, says ABPI
November 15, 2005The ABPI has indicated its discomfort with government interference in NHS decision-making on medicines following the intervention of Patricia Hewitt …
Public’s expectations of NHS too high, say doctors
November 15, 2005Most young doctors believe the public's expectations of the NHS are too high, according to a new survey.The BMA surveyed …
Animal rights and wrongs
November 14, 2005With the recent cessation of guinea pig breeding at Darley Oaks Farm, after a protracted and sometimes violent campaign by …
Health secretary backs Herceptin use
November 10, 2005North Stoke PCT will provide a mother of four with breast cancer drug Herceptin following mounting political and media pressure.Elaine …
Foundation Trust requirements relaxed
November 10, 2005The government is opening up Foundation Trust status to more hospitals as it looks to accelerate health service reform.NHS Trusts …
NICE unveils fast track plans
November 10, 2005NICE has unveiled plans to fast-track key new cancer drugs and other medicines through a new simplified appraisal process.The Institute …
Herbal medicines must prove safety
November 10, 2005Sales and Marketing
The marketing of herbal medicines will now face stricter regulation across the European Union following the introduction of new legislation. …
GSK loses out on UK Seroxat patent
November 10, 2005Sales and Marketing
GlaxoSmithKline has been defeated in a long-running battle over the UK patent on its antidepressant Seroxat.After four years of legal …
Agency to raise iron overload awareness for Novartis brand
November 10, 2005Medical Communications
Ruder Finn has been awarded the UK contract to promote Novartis' new chronic iron overload product Exjade in a campaign …
Latest content
FibroFind appoints Lee Borthwick as CEO
